Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ricketts

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Urology|October 23, 2012
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancerChristopher J Ricketts, Brian Shuch, Cathy D Vocke, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Urologic Oncology|August 23, 2025
Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kineticsDaniel Nethala, Braden Millan, Jason Hyman, et al.
Oncotarget|March 15, 2018
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.
Cancer Cell|December 10, 2014
Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancerCarole Sourbier, Christopher J Ricketts, Shingo Matsumoto, et al.
Urology|June 18, 2023
PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell CarcinomaLaura S Schmidt, Cathy D Vocke, Christopher J Ricketts, et al.
Molecular Cancer Research : MCR|May 28, 2013
A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinomaMegan N Farley, Laura S Schmidt, Jessica L Mester, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
Nature Genetics|February 7, 2012
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibilityDewi Astuti, Mark R Morris, Wendy N Cooper, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Urology|October 23, 2012
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancerChristopher J Ricketts, Brian Shuch, Cathy D Vocke, et al.
Journal of Medical Genetics|September 24, 2024
A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau diseaseCathy D Vocke, Christopher J Ricketts, Svetlana Pack, et al.
Urologic Oncology|August 23, 2025
Renal surgery following HIF-2α antagonist therapy: Surgical indications, outcomes and growth kineticsDaniel Nethala, Braden Millan, Jason Hyman, et al.
Oncotarget|March 15, 2018
Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.
Cancer Cell|December 10, 2014
Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancerCarole Sourbier, Christopher J Ricketts, Shingo Matsumoto, et al.
Urology|June 18, 2023
PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell CarcinomaLaura S Schmidt, Cathy D Vocke, Christopher J Ricketts, et al.
Molecular Cancer Research : MCR|May 28, 2013
A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinomaMegan N Farley, Laura S Schmidt, Jessica L Mester, et al.
EMBO Molecular Medicine|March 29, 2023
TFEB and TFE3 drive kidney cystogenesis and tumorigenesisChiara Di Malta, Angela Zampelli, Letizia Granieri, et al.
Nature Genetics|February 7, 2012
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibilityDewi Astuti, Mark R Morris, Wendy N Cooper, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Pageof 11